# Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy

> **NCT03364907** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Peritoneal Carcinomatosis

## Interventions

- **OTHER:** HIPEC with flushing afterwards
- **OTHER:** HIPEC without flushing afterwards

## Key facts

- **NCT ID:** NCT03364907
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2019-06-08
- **Final completion:** 2019-12-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03364907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03364907, "Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03364907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*